They merged with a us based company!

GETA is a great entry price and the buying pressure is on there also.
They still have many drugs in the pipeline and one of them will get
approved soon.

Some other stocks to buy are HTDS and EXBXE

HTDS will have a merger soon and many deals are in the works.  It will
only take one deal or merger to send this stock up 500+ percent.

EXBXE just bought a bunch of oil and gas assets worth millions for
revenue and will reduce the float by 30% any day now.

SPNG should have a report coming out some time.  Share price is a
great play and it will recover to atleast 12 cents in the very near
future.

BZCN will break a penny and if it goes to atleast 6 cents which is
half of whatit hit last year in december then that will be more then a
5000 percent gain.  BZCN opened up a new store and provides
liquidation for many companies. They address a 60 billion dollar
problem in the market place.

BIEL has FDA approval coming anytime and will begin to create large
amounts of revenue on their new product.

Each of these stocks is a great low entry price and if you buy and
hold for just 8 weeks you will make a lot of cash.  Do some DD on
these companies and then buy if you like what you read.  These are all
gold mines and are worth buying and holding

I just found these last night ..... don't you find it interesting?

From the Beijing Academy of Traditional Chinese Medicine Jinkui

Time: 2009-11-07 13:11 Source: Author: Click: 13 Times
Biopharmaceutical company Genta's antisense agent Genasense (TM)
enhances the breast cancer chemotherapy drugs & nbsp Genta bio-
pharmaceutical companies, scientists at the joint use of the company's
anti-sense agent Genasense (TM) products and chemotherapy drugs
doxorubicin treatment on mice and achieved a GOOD therapeutic effect.

FDA advisers support the drug approved for advanced breast cancer
Time: 2009-11-08 11:54 Source: Author: Click: 1 Times
FDA's oncology drug advisory committee enthusiastically supported the
North China pharmaceutical company Novartis (Novartis) production of
estrogen blocking drug Femara. This is the second year, FDA received
these drugs, earlier, FDA approved the first one of these drugs:
AstraZeneca produced by Arimidex (Anatoly yl). Novartis in the risk of
estrogen-sensitive breast tumors

http://translate.google.com/translate?hl=en&sl=zh-CN&u=http://www.767...

http://translate.googleusercontent.com/translate_c?hl=en&sl=zh-CN&tl=...

  PEACE ;)
"TAI PING" = PEACE IN CHINESE

On Nov 6, 8:01 am, Day-Trader <conceptdetailingcen...@msn.com> wrote: